No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Gallbladder Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Gallbladder drugs are used to treat gallbladder diseases, such as cholecystitis, gallstones, and biliary dyskinesia. These drugs can be administered orally, intravenously, or topically. Commonly used gallbladder drugs include ursodeoxycholic acid, chenodeoxycholic acid, and bile acid sequestrants.
Gallbladder drugs are used to reduce the risk of gallbladder disease, reduce the size of gallstones, and reduce the risk of gallbladder cancer. They are also used to reduce the risk of complications from gallbladder surgery.
Some companies in the Gallbladder Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
